| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP0937043B1 Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them |
| 03/06/2002 | EP0883403A4 Method for treating sexual dysfunctions |
| 03/06/2002 | CN1339026A Benzamide derivatives and drugs containing the same |
| 03/06/2002 | CN1338935A Release-regulating preparations |
| 03/06/2002 | CN1338934A Mono-acyloxy aralkyl neuronuscular relaxants |
| 03/06/2002 | CN1080283C Synergic stabilizato mixture |
| 03/06/2002 | CN1080264C Oxathiolanes, method for their preparation and pharmaceutical compoistions containing same |
| 03/06/2002 | CA2356545A1 Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| 03/05/2002 | US6353107 1-alkoxy-polyallkyl-piperidine derivatives and their use as polymerization regulators |
| 03/05/2002 | US6353099 Substituted ureas as cell adhesion inhibitors |
| 03/05/2002 | US6353044 Light-stabilized organic polymers |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | CA2206122C Arylacrylamide derivatives |
| 02/28/2002 | WO2002016321A1 Prodrugs to nmda receptor ligands |
| 02/28/2002 | WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | WO2002016303A1 Process for producing methacryloyl reaction product |
| 02/28/2002 | WO2002015909A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | WO2002015906A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | WO2001081343A3 Compounds for treating fibromyalgia and chronic fatigue syndrome |
| 02/28/2002 | WO2001056989A3 Inhibitors of factor xa |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026057 1-(2-(2-naphthyl)ethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6 -tetrahydropyridine hydrochloride; dissolved by heating in a solvent an alcohol, keton, DMSO or ethyl acetate solvent |
| 02/28/2002 | US20020026055 Aminopyridine-containing thiourea inhibitors of herpes viruses |
| 02/28/2002 | US20020025970 Materials and methods for the treatment of gastroesophageal reflux disease |
| 02/28/2002 | US20020025967 Antiserotinone agents |
| 02/28/2002 | US20020025947 Serine protease inhibitor |
| 02/28/2002 | CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use |
| 02/28/2002 | CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | CA2419310A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/27/2002 | EP1182193A1 Remedies for neuropathic pain |
| 02/27/2002 | EP1182192A1 4-hydroxypiperidine derivatives having antiarrhythmic effect |
| 02/27/2002 | EP1181934A1 Inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than optic circulatory disorder |
| 02/27/2002 | EP1181932A2 Therapeutic compositions comprising excess enantiomer of amlodipine |
| 02/27/2002 | EP1181278A1 Cyclic amine derivatives and their uses |
| 02/27/2002 | EP1181277A1 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| 02/27/2002 | EP1181271A2 Naphthalene ureas as glucose uptake enhancers |
| 02/27/2002 | EP1181017A1 Metalloprotease inhibitors |
| 02/27/2002 | EP0859634B1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 02/27/2002 | EP0790982B1 Methods of synthesis of peptidyl argininals |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337948A Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1079798C 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents, and the intermediate |
| 02/27/2002 | CN1079793C Process for preparation of enantiomerically pure substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
| 02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 02/26/2002 | US6350883 Method for preparing lactam |
| 02/26/2002 | US6350877 Manufacturing process |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | US6350766 Pain, cns |
| 02/26/2002 | US6350762 Dihydropyridine derivative |
| 02/26/2002 | US6350761 Benzenamine derivatives as anti-coagulants |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity |
| 02/21/2002 | WO2001072960A3 Il-8 receptor antagonists |
| 02/21/2002 | US20020022641 For therapy of metabolic disorders related to insulin resistance or hyperglycemia, typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenic inflammation, glaucoma |
| 02/21/2002 | US20020022640 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 02/21/2002 | US20020022605 Cyclamine sulfonamides as beta-3 adrenergic receptor agonists |
| 02/20/2002 | EP1180513A1 Cyclic amide compounds, process for the preparation of the same and uses thereof |
| 02/20/2002 | EP1180099A1 New compounds |
| 02/20/2002 | EP1180098A1 New compounds |
| 02/20/2002 | EP1180097A1 Mutual salt of amlodipine and atorvastatin |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336917A Amide compounds |
| 02/20/2002 | CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester |
| 02/20/2002 | CN1336821A Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their prepn. and therapeutic use |
| 02/20/2002 | CN1336365A Prepn. of 2,2,6,6-tetraalkyl-4-piperylhydrazines |
| 02/20/2002 | CN1336356A Method for prepn. of alkaline organic nitrogen-contg. compound by using aluminium lithium oxide reduction method |
| 02/19/2002 | US6348598 N-oxyl compounds, process for the preparation thereof, and process for inhibiting the polymerization of vinyl monomers with the same |
| 02/19/2002 | US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 02/14/2002 | WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012191A1 Cyclic amine derivatives and use thereof |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002012189A1 Fused bicyclic amide compounds and medicinal use thereof |
| 02/14/2002 | WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same |
| 02/14/2002 | WO2002006230A8 Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | US20020019543 Thiol derivative, metallo-beta-lactamase inhibitors |
| 02/14/2002 | US20020019535 Resolution of ritalinic acid salt |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019533 Piperidine derivatives and anti-platelet agents containing the same |
| 02/14/2002 | US20020019532 Process for the synthesis of (2S)-phenyl-3-piperidone |
| 02/14/2002 | US20020019531 Indoles |
| 02/14/2002 | US20020019419 Substituted isonipecotyl derivatives as inhibitors of cell adhesion |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example |
| 02/14/2002 | US20020019384 4-(3-((((3-(4-((3-Methylbutyl)amino)-1-piperidinyl)propyl) -amino)-carbonyl)amino)phenyl)-1,4-dihydro-2,6-dimethyl-3,5 -pyridinedicarboxylic acid, dimethyl ester dihydrochloride, for example; anorexiant; Neuropeptide Y (NPY) |
| 02/14/2002 | DE10037408A1 Verfahren zur Herstellung von basisch reagierenden, organischen, stickstoffhaltigen Verbindungen durch Reduktion mit Lithiumaluminiumhydrid Process for the preparation of basic organic nitrogen-containing compounds by reduction with lithium aluminum hydride |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |